OmniAb, Inc. (OABI)
NGM · Common · CUSIP 68218J103
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for OABI and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
68218J103
Previous Symbol
AHPA (changed 11/1/2022)
Previous Name
Avista Public Acquisition Corp. II
Business: OmniAb, Inc. uses roprietary transgenic animals, including OmniRat, OmniChicken and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. OmniAb’s discovery platform provides pharmaceutical industry partners access to diverse antibody repertoires and high-throughput screening technologies to enable discovery of next-generation therapeutics.

Company Contact

CEO
Matthew W. Foehr
CFO
Kurt Gustafson
Headquarters
5980 Horton Street, Suite 405, Emeryville, CA 94608
Phone
510-250-7800
Investor Relations
Neha Singh · 510-768-7760 · investors@omniab.com
SEC EDGAR Filings
View filings »